March 01, 2015 12:56 PM ET


Company Overview of Arisaph Pharmaceuticals, Inc.

Company Overview

Arisaph Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing therapies for cancer, cardiovascular disease, and diabetes. Its products include dipeptidylpeptidase IV inhibitors, stable GLP-1 agonists, HDL modulators and plaque reducers, and tumor activated pro-soft drugs. Arisaph Pharmaceuticals, Inc. was formerly known as Triad Pharmaceuticals, Inc. and changed its name to Arisaph Pharmaceuticals, Inc. in November 2005. The company was incorporated in 1999 and is based in Boston, Massachusetts.

100 High Street

Suite 1202

Boston, MA 02110

United States

Founded in 1999





Key Executives for Arisaph Pharmaceuticals, Inc.

Co-Founder, Chief Executive Officer, President and Director
Age: 49
Co-Founder, Chief Scientific Officer, Executive Vice President and Director
Co-Founder and Director
Age: 85
Chief Business Officer and Vice President of Finance
Senior Vice President of Drug Development
Compensation as of Fiscal Year 2014.

Arisaph Pharmaceuticals, Inc. Key Developments

Arisaph Pharmaceuticals, Inc. Presents at 2013 Therapeutic Area Partnerships Conference, Nov-19-2013 02:55 PM

Arisaph Pharmaceuticals, Inc. Presents at 2013 Therapeutic Area Partnerships Conference, Nov-19-2013 02:55 PM. Venue: One Avenue De Lafayette, Boston, MA 02111, United States.

Similar Private Companies By Industry

Company Name Region
Guy & O'Neill, Inc. United States
Nutravail Technologies Inc. United States
Alteris Therapeutics Inc. United States
Sanofi Pasteur Biologics, LLC United States
Bexion Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Arisaph Pharmaceuticals, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at